Urgent Update: New Information Regarding Recalled Breast Implants
If you have McGhan-, Inamed-, or Allergan-branded textured gel or saline-filled breast implants that were recalled in July 2019 due to FDA recommendations, this blog is essential reading. The McGhan Corporation previously sold the recalled implants. Allergan purchased McGhan’s parent company Inamed in 2006. Recent developments have shed light on the risks associated with these implants, particularly the ones identified as having “Biocell texture.” The FDA initially advised against removal in 2019, but new findings from scientific research studies published in 2023 suggest a reconsideration is in order.
Increased Risks and Latest Research: The latest research indicates a more than threefold increase in the risk of developing breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) with the recalled implants compared to the data available in 2019. This alarming revelation emphasizes the importance of staying informed and taking proactive measures to address potential health risks.
Factors Influencing Risk: Certain factors contribute to an elevated risk of BIA-ALCL, including age greater than 46, more than 6 years since breast augmentation, and the presence of breast cancer genetic markers. Understanding these risk factors is crucial for making informed decisions about your health and well-being.
Recommendation for Action: Considering the updated information, it is highly recommended that individuals with the mentioned implants seek a consultation with a board-certified plastic surgeon such as Steven Yarinsky, MD, who specializes in cosmetic surgery and breast augmentation. This will provide an opportunity for you to discuss the latest developments and address any concerns you may have.
Procedure Details: Implant removal, with or without replacement, is a much more comfortable process than the initial augmentation. The procedure is safely and usually performed in the office operating room facility at Saratoga Springs Plastic Surgery using local anesthesia and oral sedation, eliminating the preoperative medical screening (such as chest x-ray and EKG) needed for general anesthesia, and the added expense. However, general anesthesia is available at an added cost for those patients who choose to be completely asleep. The recovery process is described by most women as swift, with minimal pain compared to their original augmentation.
Insurance Coverage: It’s important to note that insurance does not typically cover this procedure. You will receive a fee quote during your consultation, and financing options if needed, allowing you to make informed decisions about the financial aspects of the recommended procedure.
In conclusion, staying informed about the latest developments regarding recalled breast implants is crucial for your health and well-being. If you have the mentioned implants, it’s recommended to schedule a consultation to discuss the updated information and address any concerns. Taking proactive steps now can contribute to your overall long-term safety and peace of mind. To schedule an appointment, call (518) 583-4019 on weekdays. Your health is of the utmost importance.
Read more about this update: Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) December 1, 2023, Update and Treatment Recommendations for Women Who Have Allergan (McGhan, Inamed) Biocell Textured Breast Implants
Previous Post